The Hemostasis & Thrombosis Research Society (HTRS) Lifetime Achievement Award honors members who have made a lasting and extraordinary contribution to research, education, mentorship, or clinical care in hemostasis or thrombosis. The 2025 award will be bestowed upon Dr. Shapiro at the organization’s Scientific Symposium in San Diego, Calif., in March.
Among Dr. Shapiro’s extensive achievements are the co-founding of the IHTC in 1998 which now under Innovative Hematology serves thousands of blood disorder patients across the state of Indiana. Under her leadership, the center has gained a multitude of national and international accolades, including recognition as a medical home, Learning Action Network clinic of excellence for women and girls with blood disorders (FWGBD), anticoagulation center of excellence (AC forum), and HHT center of excellence (Cure HHT).
Dr. Shapiro is author/co-author of more than 320 journal articles, abstracts, and textbook chapters clinically focused on improving treatment for people with rare bleeding disorders. She has served on the National Bleeding Disorders Foundation’s Medical and Scientific Advisory Council as well as several boards for the National Institutes of Health in Data Safety Monitoring and Clinical Trial Review. As one of the founders of the American Thrombosis and Hemostasis Network (ATHN), Dr. Shapiro served as Co-Chairman of the Board of Directors and remains active on various ATHN committees. Dr. Shapiro was honored as Physician of the Year by the National Bleeding Disorders Foundation and most recently received their Leadership in Research Award. Among other accomplishments, Dr. Shapiro was recognized among the Women Leaders in Hematology by the American Journal of Hematology, and she was presented with the Distinguished Hoosier Award in Indiana.
Dr. Shapiro supervises a large clinical trial program with 50 clinical trials currently open at Innovative Hematology. She supervised the first in-human infusion of multiple coagulation factors, including Ryplazim, Benefix, Vonvendi, Ixinity, and Alprolix. She also envisioned and founded a specialized physician academy to close the knowledge gap in training classical hematologists in the U.S.
What’s more, Dr. Shapiro’s passion for serving the underserved has brought important healthcare resources to Indiana’s Amish communities and across the globe from Kenya to India.
“On a personal level, Dr. Shapiro’s mentorship has been the most impactful on my career as a classical hematologist,” says Dr. Magdalena Lewandowska, a hematologist at Innovative Hematology who led the nomination effort for Dr. Shapiro’s award. “She remains an incredible role model in encouraging success of early career doctors in hematology.”
